Latest Recurrent Pregnancy Loss guidelines at ACOG
One of the highlights of attending the latest annual ACOG Clinical & Scientific meeting was joining a packed auditorium to hear Dr Ruth Lathi’s compelling lecture, “New Guidelines, New Hope for Recurrent Pregnancy Loss.” 📖 Dr. Lathi, the Director of the Multi-Specialty Recurrent Pregnancy Loss Program and Professor of Obstetrics and Gynecology at Stanford University …
WAM Forum Learnings
3 things I learned at the WAM Forum luncheon in Las Vegas! I was so delighted to be invited to attend the Women’s Alzheimer’s Movement forum networking breakfast and luncheon yesterday. Such an incredible group of people brought together to find collaboration and solutions for women’s health. Our bodies are pretty intertwined. Brain health is …
ACOG in Minneapolis
Spending time in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting was even better than I had hoped. Besides the constant engagement with passionate American OBGYNs (so many of which are excited to hear about our Callavid® drug delivery technology) – it was superb to connect with other …
Discover CLCC’s B Corp Impact Report
We believe that true success in business must be measured not just by commercial milestones, but by the positive impact we create. To us, being a B Corp is more than a certification – it’s a daily commitment to balancing people, planet, profit, and purpose. B Lab’s rigorous standards provide a clear framework for accountability …
A RCT of progesterone luteal support for unexplained infertility
A promising new study published in the BJOG Journal (British Journal of Obstetrics and Gynaecology / Royal College of Obstetricians and Gynaecologists) explores the use of vaginal progesterone for couples facing unexplained infertility. 👀 Could this pave the way for broader use of vaginal progesterone prior to IVF —especially for those who can’t access IVF …
Miscarriage Prevention: What Science Can Do And Why It’s Not Your Fault
Miscarriage. You can find lots of definitions, from the rather cold “spontaneous or unplanned expulsion of a fetus from the womb before it is able to survive independently,” to the softer “sudden loss of a pregnancy before the 20th week.” Either way, it sucks. If you have had one, I’m sorry. So why do women …
Lara Joins Springboard Women’s Health Accelerator 2025 Cohort
Our co-founder Lara Zibners MD MMEd MBA has been selected to join the Springboard Enterprises 2025 Women’s Health Cohort! Lara joins a cohort featuring 12 companies that are driving innovation in areas that differently, predominantly, or solely impact women. Over the next 3 months, the selected entrepreneurs will participate in an intensive accelerator program, working …
LSI Emerging Medtech Conference Day 1
The first day of the LSI Emerging Medtech conference in Dana Point, CA was superb – capped off by our well-received presentation on our Callavid® vaginal drug delivery platform. 💪 No doubt buoyed by the momentum surrounding opportunities in women’s health – there was a real buzz leading up to and following our presentation. We’re …
Attending LSI USA 25
We’re delighted to be heading to Dana Point, CA during the LSI conference! From March 17th-21st, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at one of medtech’s premier partnering events. This is an exciting opportunity to discuss new trends, potential collaborations, and meet with valued partners and industry …
Lara discussing the role of Innovation in Closing the Gender Healthcare Gap
Still buzzing from an exceptional Future of Healthtech Hub event last night hosted by THENA Capital at M&G Investments. A memorable night between the intimate crowd and superb panel of experts including Professor Dame Lesley Regan (the UK’s Women’s Health Ambassador for England), Alliott Cole, MD of Octopus Ventures (member of the Invest in Women …